| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, November 2007, p. 4196-4201, Vol. 51, No. 11
0066-4804/07/$08.00+0 doi:10.1128/AAC.00827-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
,
Department of Pathology, Hershey Medical Center, Hershey, Pennsylvania
Received 25 June 2007/ Returned for modification 10 July 2007/ Accepted 16 July 2007
Testing of 12 pneumococcal strains with differing resistotypes [including tet(M) positive] showed that tigecycline, amoxicillin-clavulanate, imipenem, and ceftriaxone did not select for resistant clones after 50 sequential subcultures. By comparison, azithromycin, clarithromycin, clindamycin, telithromycin, levofloxacin, moxifloxacin, and gemifloxacin did show resistant clones. Tigecycline also yielded a low frequency of resistance in single-step tests compared to all ß-lactams, macrolides/ketolides, and quinolones tested.
Published ahead of print on 17 September 2007.
Supplemental material for this article may be found at http://aac.asm.org/.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |